Theodore Argyrakos

Galectin-3 as a marker distinguishing functioning from silent corticotroph adenomas.

Eleni Thodou, Theodore Argyrakos, George Kontogeorgos · PubMed · 2007 · 30 citations

Medicine, Endocrinology, Neuroscience +12

Recurrent Fulminant Tumefactive Demyelination With Marburg-Like Features and Atypical Presentation: Therapeutic Dilemmas and Review of Literature

Aigli G. Vakrakou, Dimitrios Tzanetakos, Theodore Argyrakos et al. · Frontiers in Neurology · 2020 · 22 citations · Full text

Medicine, Neurology, Neuroscience +17

Clinico-radiologic features and therapeutic strategies in tumefactive demyelination: a retrospective analysis of 50 consecutive cases

Aigli G. Vakrakou, Dimitrios Tzanetakos, Theodore Argyrakos et al. · Therapeutic Advances in Neurological Disorders · 2021 · 20 citations · Full text

Medicine, Neurology, Radiology +15

Anaplastic lymphoma kinase expression and gene alterations in glioblastoma: correlations with clinical outcome

G. Karagkounis, George Stranjalis, Theodore Argyrakos et al. · Journal of Clinical Pathology · 2016 · 16 citations

Medicine, Oncology, Pathology +17

An unusual case of desmoid tumour presenting as haemorrhagic shock

C Georgiades, Natalia G. Vallianou, Theodore Argyrakos et al. · Annals of The Royal College of Surgeons of England · 2012 · 14 citations · Full text

Medicine, Hematology, Surgery +9